Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | non-specific serine/threonine protein kinase | 0.0038 | 0.0984 | 0.041 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0107 | 0.5402 | 0.5402 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0097 | 0.4745 | 0.4745 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.006 | 0.2407 | 0.2407 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0179 | 1 | 1 |
Trypanosoma brucei | rac serine-threonine kinase, putative | 0.0036 | 0.0865 | 0.0138 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0026 | 0.0247 | 0.0247 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0034 | 0.0737 | 0.0737 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.0025 | 0.0145 | 0.0141 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0142 | 0.7663 | 0.7663 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0133 | 0.7073 | 0.7073 |
Echinococcus granulosus | serine:threonine protein kinase SMG1 | 0.0034 | 0.0737 | 0.0734 |
Entamoeba histolytica | protein kinase, putative | 0.0034 | 0.0723 | 0.072 |
Echinococcus multilocularis | serine:threonine protein kinase SMG1 | 0.0034 | 0.0737 | 0.0734 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0107 | 0.5402 | 0.5402 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0133 | 0.7073 | 1 |
Schistosoma mansoni | phosphatidylinositol 3-and 4-kinase | 0.006 | 0.2407 | 0.2296 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0179 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.012 | 0.6239 | 0.6239 |
Schistosoma mansoni | fkbp-rapamycin associated protein | 0.0034 | 0.0737 | 0.0601 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0048 | 0.1641 | 0.1641 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0097 | 0.4745 | 0.4745 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0133 | 0.7073 | 0.7073 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0096 | 0.4735 | 0.4735 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0133 | 0.7073 | 0.7073 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.0179 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0116 | 0.5992 | 0.5992 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.0179 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0133 | 0.7073 | 0.7073 |
Brugia malayi | Protein kinase domain containing protein | 0.0036 | 0.0865 | 0.0634 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0097 | 0.4745 | 0.4745 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.0142 | 0.7672 | 0.7672 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0107 | 0.5402 | 0.5402 |
Trichomonas vaginalis | AGC family protein kinase | 0.0036 | 0.0865 | 0.0865 |
Leishmania major | target of rapamycin (TOR) kinase 2, putative | 0.0179 | 1 | 1 |
Echinococcus multilocularis | PIK kinase, FAT and Armadillo domain containing protein | 0.0026 | 0.0247 | 0.0243 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0034 | 0.0737 | 0.0503 |
Trypanosoma cruzi | rac serine-threonine kinase, putative | 0.0025 | 0.0145 | 0.0145 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0737 | 0.0737 |
Trichomonas vaginalis | AGC family protein kinase | 0.0036 | 0.0865 | 0.0865 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0106 | 0.5335 | 0.5335 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0096 | 0.4735 | 0.4735 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.006 | 0.2407 | 0.2407 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0106 | 0.5335 | 0.5335 |
Trichomonas vaginalis | AGC family protein kinase | 0.0036 | 0.0865 | 0.0865 |
Echinococcus granulosus | PIK kinase FAT and Armadillo domain containing protein | 0.0026 | 0.0247 | 0.0243 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0034 | 0.0737 | 0.0737 |
Toxoplasma gondii | FATC domain-containing protein | 0.0034 | 0.0737 | 0.0021 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase, putative | 0.0034 | 0.0737 | 0.0737 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0133 | 0.7073 | 0.7073 |
Giardia lamblia | GTOR | 0.0179 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0026 | 0.0247 | 0.0103 |
Echinococcus multilocularis | serine protein kinase ATM | 0.0034 | 0.0737 | 0.0734 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0179 | 1 | 1 |
Echinococcus multilocularis | phosphatidylinositol 3 and 4 kinase | 0.006 | 0.2407 | 0.2405 |
Trichomonas vaginalis | AGC family protein kinase | 0.0036 | 0.0865 | 0.0865 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.006 | 0.2407 | 0.1803 |
Leishmania major | target of rapamycin (TOR) kinase 1, putative | 0.0179 | 1 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.006 | 0.2407 | 0.2215 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0142 | 0.7663 | 0.7663 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0034 | 0.0737 | 0.0737 |
Loa Loa (eye worm) | AGC/RSK/P70 protein kinase | 0.0034 | 0.0723 | 0.0723 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.006 | 0.2407 | 0.2407 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0038 | 0.0984 | 0.0984 |
Trichomonas vaginalis | AGC family protein kinase | 0.0036 | 0.0865 | 0.0865 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0179 | 1 | 1 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0179 | 1 | 1 |
Echinococcus granulosus | serine/threonine protein kinase | 0.0025 | 0.0145 | 0.0141 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.006 | 0.2407 | 0.2407 |
Echinococcus granulosus | serine protein kinase ATM | 0.0034 | 0.0737 | 0.0734 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.006 | 0.2407 | 0.2407 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.006 | 0.2407 | 0.2407 |
Trypanosoma brucei | phosphatidylinositol 3-kinase tor, putative | 0.0085 | 0.3979 | 0.35 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0904 | 0.0904 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.006 | 0.2407 | 0.2407 |
Brugia malayi | p70 ribosomal S6 kinase beta | 0.0034 | 0.0723 | 0.0489 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.0984 | 0.0984 |
Plasmodium vivax | rac-beta serine/threonine protein kinase, putative | 0.0022 | 0.0004 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0179 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0034 | 0.0737 | 0.0734 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0179 | 1 | 1 |
Trypanosoma brucei | FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative | 0.0074 | 0.3321 | 0.279 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0034 | 0.0737 | 0.0503 |
Entamoeba histolytica | protein kinase, putative | 0.0036 | 0.0865 | 0.0861 |
Entamoeba histolytica | protein kinase rad3, putative | 0.0034 | 0.0737 | 0.0734 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0142 | 0.7663 | 0.7663 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.006 | 0.2407 | 0.2407 |
Leishmania major | target of rapamycin kinase (TOR) kinase 3 | 0.0142 | 0.7672 | 0.6934 |
Trichomonas vaginalis | AGC family protein kinase | 0.0036 | 0.0865 | 0.0865 |
Loa Loa (eye worm) | AGC/AKT protein kinase | 0.0036 | 0.0865 | 0.0865 |
Plasmodium falciparum | RAC-beta serine/threonine protein kinase | 0.0022 | 0.0004 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0133 | 0.7073 | 0.7073 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0142 | 0.7672 | 0.7487 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0096 | 0.4735 | 0.4735 |
Trypanosoma cruzi | Protein kinase B | 0.0025 | 0.0145 | 0.0145 |
Entamoeba histolytica | protein kinase, putative | 0.0036 | 0.0865 | 0.0861 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.0179 | 1 | 1 |
Echinococcus granulosus | phosphatidylinositol 3 and 4 kinase | 0.006 | 0.2407 | 0.2405 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0133 | 0.7073 | 0.7073 |
Entamoeba histolytica | Phosphatidylinositol 3- and 4-kinase family | 0.0034 | 0.0737 | 0.0734 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.0025 | 0.0145 | 0.0141 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.006 | 0.2407 | 0.1803 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0142 | 0.7663 | 0.7663 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0097 | 0.4745 | 0.4745 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0034 | 0.0737 | 0.0737 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.0179 | 1 | 1 |
Echinococcus multilocularis | rac serine:threonine kinase | 0.0025 | 0.0145 | 0.0141 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0247 | 0.0247 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0153 | 0.833 | 0.833 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm) | 0.0034 | 0.0737 | 0.0601 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0179 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0142 | 0.7663 | 0.7663 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0179 | 1 | 1 |
Trypanosoma cruzi | rac serine-threonine kinase, putative | 0.0022 | 0.0004 | 0.0004 |
Trichomonas vaginalis | AGC family protein kinase | 0.0036 | 0.0865 | 0.0865 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -5.769 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.742 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.681 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.629 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.612 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.579 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.532 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.527 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.51 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.